Search by Drug Name or NDC

    NDC 00093-9703-05 Carbidopa and levodopa 25; 250 mg/1; mg/1 Details

    Carbidopa and levodopa 25; 250 mg/1; mg/1

    Carbidopa and levodopa is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is CARBIDOPA; LEVODOPA.

    Product Information

    NDC 00093-9703
    Product ID 0093-9703_6989f93b-c2be-4026-89b3-5cb7c4a77b73
    Associated GPIs
    GCN Sequence Number 002539
    GCN Sequence Number Description carbidopa/levodopa TABLET 25MG-250MG ORAL
    HIC3 H6A
    HIC3 Description ANTIPARKINSONISM DRUGS,OTHER
    GCN 62742
    HICL Sequence Number 013894
    HICL Sequence Number Description CARBIDOPA/LEVODOPA
    Brand/Generic Generic
    Proprietary Name Carbidopa and levodopa
    Proprietary Name Suffix n/a
    Non-Proprietary Name Carbidopa and levodopa
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25; 250
    Active Ingredient Units mg/1; mg/1
    Substance Name CARBIDOPA; LEVODOPA
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074260
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-9703-05 (00093970305)

    NDC Package Code 0093-9703-05
    Billing NDC 00093970305
    Package 500 TABLET in 1 BOTTLE (0093-9703-05)
    Marketing Start Date 2023-12-15
    NDC Exclude Flag N
    Pricing Information N/A